Goralatide TFA

• CAT Number: I043726
• CAS Number: 1796568-94-9
• Molecular Formula: C22H34F3N5O11
• Molecular Weight: 601.53
• Purity: ≥95%
• Synonyms: (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-6-aminohexanoyl]pyrrolidine-2-carboxylic acid;2,2,2-trifluoroacetic acid
• InChI: InChI=1S/C20H33N5O9.C2HF3O2/c1-11(27)22-14(10-26)18(31)24-13(9-16(28)29)17(30)23-12(5-2-3-7-21)19(32)25-8-4-6-15(25)20(33)34;3-2(4,5)1(6)7/h12-15,26H,2-10,21H2,1H3,(H,22,27)(H,23,30)(H,24,31)(H,28,29)(H,33,34);(H,6,7)/t12-,13-,14-,15-;/m0./s1
• InChIKey: LKOFRAPICMDYPN-WFGXUCIJSA-N
• SMILES: CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)O.C(=O)(C(F)(F)F)O

Goralatide TFA（Cat No.:I043726）is the trifluoroacetate salt form of Goralatide, a synthetic peptide being explored for therapeutic applications, particularly in oncology and regenerative medicine. As a peptide, Goralatide targets specific cellular receptors to modulate biological processes such as cell proliferation, differentiation, and apoptosis. The TFA (trifluoroacetate) salt form enhances the stability and solubility of the peptide, making it suitable for research and potential clinical use. Goralatide TFA is being investigated for its role in tissue repair, cancer therapy, and possibly other diseases, with research focusing on its efficacy and safety in various applications.